PDCD1 and neoplasm: In our study conducted in mice bearing colorectal tumors (approximately 50 mm2), the starting PD-1 blockade simultaneously with Folfox chemotherapy drove rapid and complete tumor regression in 60% of mice [34], whereas delaying or advancing anti-PD-1 therapy by 5 days led to increased tumor relapse (unpublished data).